Title : Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.

Pub. Date : 2020

PMID : 32921987






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer. Tamoxifen epiregulin Homo sapiens
2 Conclusion: Fatostatin could induce ER degradation by K48-linked polyubiquitination, which was the key mechanism contributing to tamoxifen inhibition of PI3K-AKT-mTOR signalling in breast cancer. Tamoxifen epiregulin Homo sapiens